Jeff Yass’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36K Buy
+12,300
New +$39.6K ﹤0.01% 12992
2025
Q1
– Sell
-10,000
Closed -$23.2K – 12404
2024
Q4
$23.2K Buy
+10,000
New +$31.1K ﹤0.01% 11894
2024
Q2
– Sell
-20,200
Closed -$63K – 11968
2024
Q1
$63K Sell
20,200
-13,300
-40% -$53K ﹤0.01% 11462
2023
Q4
$130K Buy
+33,500
New +$113K ﹤0.01% 11106
2022
Q4
– Sell
-13,000
Closed -$64K – 12322
2022
Q3
$64K Buy
13,000
+100
+0.8% +$405 ﹤0.01% 12041
2022
Q2
$39K Buy
+12,900
New +$40.7K ﹤0.01% 12102
2022
Q1
– Sell
-14,600
Closed -$43K – 12918
2021
Q4
$43K Sell
14,600
-25,100
-63% -$101K ﹤0.01% 12617
2021
Q3
$189K Buy
+39,700
New +$179K ﹤0.01% 11548

Other funds holding ANIX

Jeff Yass's ANIX Position: Q3 2026 in Review

Jeff Yass opened a new position in Anixa Biosciences (ANIX) in Q3 2026: 54,926 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #12171 among its holdings. This is a return to the name: Jeff Yass previously reported a position in ANIX as recently as Q1 2026.

Jeff Yass first reported a position in ANIX in Q3 2015 and has held it in 21 quarters since. The position peaked at $1.06M in Q1 2024. 75 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

  • Jeff Yass held 54,926 shares of Anixa Biosciences worth $161K as of Q3 2026.
  • Anixa Biosciences was a new Jeff Yass position in Q3 2026.
  • Anixa Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12171 holding.
  • Jeff Yass first reported a position in Anixa Biosciences in Q3 2015 and has held it in 21 quarters since.
  • Jeff Yass's Anixa Biosciences position peaked at $1.06M in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.